{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000431","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.386732+00:00","generated_at":"2026-06-20T18:27:32.224139+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Orthofix reports Q4 net sales $122.2M (-2% YoY); SeaSpine Q4 $63.2-63.7M (+13%+); merger closed Jan 5","bullets":["Orthofix Q4 net sales $122.2M, down ~2% YoY; constant currency flat; Bone Growth Therapies up ~3%.","SeaSpine Q4 net sales $63.2-63.7M, up >13% YoY; U.S. Spinal Implants +23%, U.S. Orthobiologics +19%.","Full-year: Orthofix $460.7M (-0.8% as reported); SeaSpine ~$237.6M (+24% YoY).","Cash: Orthofix $51M; SeaSpine $29M; Orthofix borrowed $30M on revolver for merger expenses.","Merger of equals completed Jan 5; SeaSpine shareholders receiving 0.4163 OFIX shares per share."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000431","json":"https://secwatch.observer/filing/0000950170-23-000431.json","markdown":"https://secwatch.observer/filing/0000950170-23-000431.md","text":"https://secwatch.observer/filing/0000950170-23-000431.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/0000950170-23-000431-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/ofix-20230109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T18:27:32.224139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a1e5ba3fae11682a4601949398d933c9d093f23","claim":"Orthofix Medical Inc. reported preliminary financial results for the fiscal quarter and year ended December 31, 2022.","evidence_excerpt":"On January 9, 2023, Orthofix Medical Inc. (the “Company”) issued a news release announcing, among other things, its preliminary unaudited net sales for the fiscal quarter and year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/0000950170-23-000431-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter and year ended December 31, 2022"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}